Related Experiment Video
Updated: Sep 22, 2025

Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis
Published on: July 18, 2017
[Peritoneal dialysis-associated peritonitis caused by Rhizobium species - a case report]
Allan Zhao1, Anna Andersson2, Oscar Backrud3
1läkarexamen, doktorand, institutionen för fysiologi och farmakologi, Karolinska institutet.
Abstract:
Peritonitis is a serious complication associated with high morbidity and mortality in patients with peritoneal dialysis (PD). We present a case of PD-associated peritonitis caused by the unusual pathogen Rhizobium. After therapy failure and bacterial growth despite treatment with vancomycin and tobramycin, the treatment was changed to meropenem intravenously and ciprofloxacin intraperitoneally according to antimicrobial susceptibility testing. The patient subsequently recovered without having the PD-catheter removed. To conclude, patients with PD are one of many patient groups at a greater risk of infections with unusual microbial agents, and pathogens that normally do not cause disease should be considered as potential causes of pathology when antibiotic treatment failure occurs.
Insights
Peritonitis in peritoneal dialysis (PD) patients can be severe. This case highlights Rhizobium as an unusual cause, emphasizing tailored antibiotic therapy for successful treatment and PD catheter preservation.
Area of Science:
- Nephrology
- Infectious Diseases
- Microbiology
Background:
- Peritonitis is a significant complication in patients undergoing peritoneal dialysis (PD).
- High rates of morbidity and mortality are associated with PD-related peritonitis.
- Prompt and accurate diagnosis is crucial for effective management.
Observation:
- A case of PD-associated peritonitis caused by the rare pathogen Rhizobium is presented.
- Initial treatment with vancomycin and tobramycin failed, with persistent bacterial growth.
- Antimicrobial susceptibility testing guided a change in therapy.
Findings:
- Intravenous meropenem and intraperitoneal ciprofloxacin were administered based on susceptibility results.
- The patient recovered successfully without the need for PD-catheter removal.
- This demonstrates the efficacy of targeted antimicrobial therapy against unusual pathogens.
Implications:
- Patients on PD are susceptible to infections by uncommon microbial agents.
- Unusual pathogens should be considered in cases of antibiotic treatment failure in PD peritonitis.
- Preserving the PD catheter through effective treatment is a key goal in managing PD-associated infections.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis III: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Peritoneal Dialysis I: Introduction and Procedure

